BiotechTube

HSK7653 10mg Q2W + HSK7653 25mg Q2W + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Impaired Glucose Tolerance

Conditions

Impaired Glucose Tolerance

Trial Timeline

Mar 29, 2021 → Jun 29, 2022

NCT ID
NCT04727580

About HSK7653 10mg Q2W + HSK7653 25mg Q2W + Placebo

HSK7653 10mg Q2W + HSK7653 25mg Q2W + Placebo is a phase 2 stage product being developed by Haisco Pharmaceutical Group for Impaired Glucose Tolerance. The current trial status is completed. This product is registered under clinical trial identifier NCT04727580. Target conditions include Impaired Glucose Tolerance.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04727580Phase 2Completed

Competing Products

19 competing products in Impaired Glucose Tolerance

See all competitors
ProductCompanyStageHype Score
Aspirin + Alpha lipoic acid + Olmesartan + PlaceboDaiichi SankyoPre-clinical
23
ASP8825Astellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
GilteritinibAstellas PharmaPhase 1
33
fospropofol + fospropofol + fospropofol + fospropofolEisaiPre-clinical
23
Exenatide + MetforminEli LillyApproved
85
Apatinib MesylateJiangsu Hengrui MedicinePhase 1
33
balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg + balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg + dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozinAstraZenecaPhase 3
77
Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)MerckPre-clinical
23
ASA404NovartisPhase 1
33
MAS825 + Standard of Care (SoC)NovartisPhase 2
52
DFV890 + Standard of Care (SoC)NovartisPhase 2
52
Immediate switch to TDF/FTC/RPV + Switch to TDF/FTC/RPV after 24 weeksGilead SciencesApproved
84
Gabapentin + Gabapentin + Gabapentin + GabapentinPfizerApproved
84
Ramipril + RosiglitazonePfizerPhase 3
76
NBI-98854 50 mg capsuleNeurocrine BiosciencesPhase 1
30
BIS-001ERSupernus PharmaceuticalsPhase 1/2
36
GFT505 80mg + PlaceboGenfitPhase 2
44

Other Products from Haisco Pharmaceutical Group

Crisugabalin + PlaceboApproved
82
Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDApproved
82
Cyclopofol + PropofolApproved
82
Ciprofol + PropofolApproved
82
CipepofolApproved
82